1.
Kissoon N, Daniels R, van der Poll T, Finfer S, Reinhart K. Sepsis-The Final Common
Pathway to Death From Multiple Organ Failure in Infection. Crit Care Med. 2016; 44(6):e446.
2.
Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care--reasons for caution.
N Engl J Med. 2014; 370(18):1673-6.
3.
Dhital R, Basnet S, Poudel DR. Predictors and outcome of invasive mechanical ventilation
in hospitalized patients with sepsis: data from National Inpatient Sample. J Community
Hosp Intern Med Perspect. 2018; 8(2):49-52.
4.
Loss SH, de Oliveira RP, Maccari JG, Savi A, Boniatti MM, Hetzel MP, Dallegrave DM,
Balzano Pde C, Oliveira ES, Hoher JA, et al. The reality of patients requiring prolonged
mechanical ventilation: a multicenter study. Rev Bras Ter Intensiva. 2015; 27(1):26-35.
5.
Lone NI, Walsh TS. Prolonged mechanical ventilation in critically ill patients: epidemiology,
outcomes and modelling the potential cost consequences of establishing a regional
weaning unit. Crit Care. 2011; 15(2):R102.
6.
Choi HS. Respiratory review of 2013: critical care medicine. Tuberculosis and respiratory
diseases. 2013; 75(1):1-8.
7.
Shehabi Y, Bellomo R, Reade MC, Bailey M, Bass F, Howe B, McArthur C, Seppelt IM,
Webb S, Weisbrodt L, et al. Early intensive care sedation predicts long-term mortality
in ventilated critically ill patients. Am J Respir Crit Care Med. 2012; 186(8):724-31.
9.
Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW,
Kress JP, Joffe AM, et al. Clinical practice guidelines for the management of pain,
agitation, and delirium in adult patients in the intensive care unit. Crit Care Med.
2013; 41(1):263-306.
10.
Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson
PL, Weinhouse GL, Nunnally ME, Rochwerg B, et al. Executive Summary: Clinical Practice
Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium,
Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;
46(9):1532-48.
11.
Adams R, Brown GT, Davidson M, Fisher E, Mathisen J, Thomson G, Webster NR. Efficacy
of dexmedetomidine compared with midazolam for sedation in adult intensive care patients:
a systematic review. Br J Anaesth. 2013; 111(5):703-10.
12.
Chang Y, Huang X, Liu Z, Han G, Huang L, Xiong YC, Wang Z. Dexmedetomidine inhibits
the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages
in vitro. The Journal of surgical research. 2013; 181(2):308-14.
13.
McGrane S, Girard TD, Thompson JL, Shintani AK, Woodworth A, Ely EW, Pandharipande
PP. Procalcitonin and C-reactive protein levels at admission as predictors of duration
of acute brain dysfunction in critically ill patients. Critical care (London, England).
2011; 15(2):R78.
14.
Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, Herr
DL, Maze M, Ely EW, investigators M. Effect of dexmedetomidine versus lorazepam on
outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized
controlled trial. Crit Care. 2010; 14(2):R38.
15.
Kawazoe Y, Miyamoto K, Morimoto T, Yamamoto T, Fuke A, Hashimoto A, Koami H, Beppu
S, Katayama Y, Itoh M, et al. Effect of Dexmedetomidine on Mortality and Ventilator-Free
Days in Patients Requiring Mechanical Ventilation With Sepsis: A Randomized Clinical
Trial. JAMA. 2017; 317(13):1321-8.
16.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M,
Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care interventions: explanation
and elaboration. J Clin Epidemiol. 2009; 62(10):e1-34.
17.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R,
Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus Definitions
for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10.
18.Schoenfeld DA, Bernard GR; ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical
trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30(8):1772-7.
20.
Tasdogan M, Memis D, Sut N, Yuksel M. Results of a pilot study on the effects of propofol
and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe
sepsis. Journal of clinical anesthesia. 2009; 21(6):394-400.
22.
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample
size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018; 27(6):1785-805.
23.
Guo F, Wang Q, Yan C, Huang H, Yu X, Tu L. Clinical application of different sedation
regimen in patients with septic shock. National medical journal of china. 2016; 96(22):1758‐61.
24.
Chen K, Lu Z, Xin YC, Cai Y, Chen Y, Pan SM. Alpha-2 agonists for long-term sedation
during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev.
2015; 1:CD010269.
25.
Reardon DP, Anger KE, Adams CD, Szumita PM. Role of dexmedetomidine in adults in the
intensive care unit: an update. Am J Health Syst Pharm. 2013;70(9):767-77.
26.Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Jan. CADTH Rapid Response Reports. Dexmedetomidine for Sedation of Patients in the ICU or PICU: Review of Clinical Effectiveness and Safety
27.
Bodet-Contentin L, Frasca D, Tavernier E, Feuillet F, Foucher Y, Giraudeau B. Ventilator-Free
Day Outcomes Can Be Misleading. Crit Care Med. 2018; 46(3):425-9.
28.
Zamani MM, Keshavarz-Fathi M, Fakhri-Bafghi MS, Hirbod-Mobarakeh A, Rezaei N, Bahrami
A, Nader ND. Survival benefits of dexmedetomidine used for sedating septic patients
in intensive care setting: A systematic review. J Crit Care. 2016; 32:93-100.